Filing Flows

Filing Flows › BeOne Medicines (ONC) › Who owns the stock

Who owns BeOne Medicines (ONC) stock

275 funds reported BeOne Medicines (ONC) shares in their latest 13F filings, worth $9.7B in all. The largest holder is Baker Bros. Advisors LP ($2.5B). Last quarter 153 funds added to their stakes and 98 cut them.

Largest holders of ONC (13F)Largest holders of ONC (13F)Baker Bros. Advisors LP$2.5BPrimecap Management$1.4BCapital International Investors$1.2BFMR LLC$706MCapital World Investors$641MCitadel Advisors LLC$406MPrice T Rowe Associates$216MBlackRock$198MMillennium Management LLC$155MMorgan Stanley$142M

Largest holders (13F)

FundSharesValueChangeQuarter
Baker Bros. Advisors LP8,801,567$2.5Bincrease2026-06-30
Primecap Management5,007,931$1.4Bincrease2026-06-30
Capital International Investors4,210,221$1.2Bincrease2026-06-30
FMR LLC2,478,527$706Mdecrease2026-06-30
Capital World Investors2,249,582$641Mincrease2026-06-30
Citadel Advisors LLC1,425,517$406Mincrease2026-06-30
Price T Rowe Associates758,752$216Mincrease2026-06-30
BlackRock694,618$198Mincrease2026-06-30
Millennium Management LLC543,323$155Mincrease2026-06-30
Morgan Stanley497,437$142Mincrease2026-06-30
Siren, L.L.C.465,000$133Munchanged2026-06-30
Bank of America439,336$125Mincrease2026-06-30
Baird Financial Group368,978$105Mincrease2026-06-30
Man Group307,463$87.6Mincrease2026-06-30
Capital International305,477$87.1Mincrease2026-06-30

BeOne Medicines' latest quarter

BeOne Medicines, Q3 2026: revenue $1.9B (+34% year over year), operating margin 22.2%, net earnings $385M, operating cash flow $509M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most ONC stock?

By the latest 13F filings: Baker Bros. Advisors LP ($2.5B); Primecap Management ($1.4B); Capital International Investors ($1.2B); FMR LLC ($706M); Capital World Investors ($641M).

What is the short interest in ONC?

1,792,875 shares were sold short at the 2026-10-15 settlement, -7.25% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.